I think if the news is very good then we will see more than 100% gain in the SP. But if it's not what we are hoping for the drop in the SP won't be huge because the Company has other revenue generating products. However,am more inclined to think that we will be told that progress is encouraging but more time and trials are needed!!
There was a short report in the Sunday Business Post (Dublin) yesterday to the effect that Amyrt are in negotiation with regulators in Britain & France "and other European countries" to have Metreleptin approved for payment reimbursement....if that means anything to the rest of you guys?